Collegium Pharmaceutical, Inc.
Moat Score — Collegium Pharmaceutical, Inc.
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | Proprietary DETERx abuse-deterrent technology and Jornay PM's unique, patent-protected evening-dosing mechanism provide genuine, differentiated IP. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | No structural manufacturing cost advantage versus larger pharmaceutical peers; margins are driven by branded pricing rather than cost leadership. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Differentiated abuse-deterrent and evening-dosing formulations support premium branded pricing versus generic alternatives in both categories. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | No network effect applies to specialty pharmaceutical products. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Once patients and physicians find a stable, effective regimen (particularly Jornay PM's specific dosing benefit), some switching reluctance exists, though generic alternatives remain accessible. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | Both pain management and ADHD are large markets that support numerous competitors, offering minimal efficient-scale protection for Collegium's niche products. |